Discovery Cut · 2:12 · English

Peptides in 2TM · Insulin & Glucagon

Insulin & Glucagon — How Two Hormones Balance Blood Sugar

In January 1922, a more purified pancreatic extract sharply lowered a critically ill teenager’s blood sugar at Toronto General Hospital. In 1923, researchers in Rochester, New York, reported a factor in pancreatic extracts that could send blood sugar in the opposite direction.

Those discoveries help explain a change that happens every day. After you eat, insulin helps the body use and store glucose. As absorption from the meal tapers off, glucagon helps the liver keep glucose available. Follow both discoveries, see why the liver matters when glucagon is used as rescue medicine, and find out where GLP-1 fits. [1–9]

English narration with optional English captions.

Inside the film

Select a time to play from that point.

  1. Two hormones, opposite effects
  2. Toronto, 1921 — the search for insulin
  3. Leonard Thompson and the January 1922 turning point
  4. Rochester, 1923 — the discovery of glucagon
  5. After a meal — how insulin works
  6. Between meals — how glucagon works
  7. Severe low blood sugar and rescue glucagon
  8. Where GLP-1 fits

Discovery history and physiology

From the laboratory to Leonard Thompson

In 1921, Frederick Banting and Charles Best tested pancreatic extracts at the University of Toronto in physiologist J. J. R. Macleod’s laboratory. Biochemist James Collip improved the purity of the preparation. The Toronto General Hospital records show why that mattered. Fourteen-year-old Leonard Thompson received an early extract on January 11, 1922, with limited clinical improvement. On January 23, the preparation purified by Collip produced a much clearer response. Walter Campbell directed the clinical care. He and Andrew Fletcher coauthored the March 1922 clinical report with Banting, Best and Collip. [1–3]

Rochester and the discovery of glucagon

At the University of Rochester in 1923, Charles P. Kimball and John R. Murlin reported a glucose-raising factor in pancreatic extracts. They called it glucagon. The early experiments tracked what the extracts did to blood glucose. Later research identified the hormone’s structure and explained how it acts on the liver. [4, 5, 7]

What happens after a meal and between meals

What happens after a meal and between meals
After a carbohydrate-containing mealSignal from the pancreasBeta cells release insulin as blood glucose rises.What happens nextSkeletal muscle and fat take up glucose. The liver reduces its glucose output and stores some glucose as glycogen.
Between mealsSignal from the pancreasInsulin falls, and glucagon from alpha cells helps sustain the liver’s glucose output.What happens nextThe liver can draw on glycogen stores and make new glucose, helping keep fuel available for the brain and other tissues.

Glycogen is a stored form of glucose. As a fast continues and liver glycogen declines, making new glucose becomes more important. [6, 7]

Why rescue glucagon depends on the liver

Glucagon medications can raise blood glucose in severe hypoglycemia. The U.S. prescribing information for glucagon injection explains that its effect depends on sufficient liver glycogen. Starvation is one circumstance in which those stores may be too low for the expected response. [8]

Where GLP-1 fits

GLP-1 stands for glucagon-like peptide 1. It is a gut hormone released in response to nutrients. It can increase insulin release in a glucose-dependent manner and suppress glucagon secretion. This is the connection to the GLP-1 pathway explored in the Exenatide episode. [9]

The complete English transcript

Two hormones, one puzzle

Two hormones from the same organ can push blood sugar in opposite directions. The story begins a century ago, with a critically ill boy in Toronto and a surprise in a Rochester laboratory.

Toronto, 1921 — the insulin research

In 1921, at the University of Toronto, Frederick Banting and Charles Best tested pancreatic extracts in the laboratory of physiologist John Macleod. Biochemist James Collip made the extract purer.

January 23, 1922 — the clinical turning point

At Toronto General Hospital, the first injection gave 14-year-old Leonard Thompson only a modest response. On January 23, 1922, Collip’s preparation brought his blood sugar down sharply. The boy improved.

Rochester, 1923 — the discovery of glucagon

Then came a surprise. In 1923, at the University of Rochester in New York, Charles Kimball and John Murlin reported a substance in pancreatic extracts that raised blood sugar. They called it glucagon.

After a meal — insulin

Today we know that both signals come from tiny clusters of cells in the pancreas. After a meal, beta cells release insulin. Muscle and fat take up glucose, and the liver stores some as glycogen.

Between meals — glucagon

Between meals, insulin levels fall. Glucagon from alpha cells tells the liver to release glucose. The liver can break down stored glycogen or make new glucose, helping maintain fuel for the brain.

Glucagon as rescue medicine

That same liver response makes glucagon useful as a rescue medicine for severe low blood sugar. If the liver’s glycogen is depleted, as in starvation, rescue glucagon can be less effective.

The GLP-1 connection

And that brings us to GLP-1. This gut hormone can boost insulin release when glucose is elevated and help suppress glucagon. Two discoveries, a century ago, still help us explain what happens after every meal.

World Peptide Foundation

World Peptide Foundation. Peptides in 2. Every experience matters.

Published at the owner’s request. Independent scientific review is pending and no human scientific review is recorded. AI-assisted source verification.

Original sources & further reading

  1. [1] University of Toronto, The Discovery and Early Development of Insulin — the Toronto team and research program.
  2. [2] University of Toronto, Leonard Thompson archival exhibit — the January 11 and January 23 entries and clinical context.
  3. [3] Banting, Best, Collip, Campbell and Fletcher, 1922 clinical report — early clinical findings with pancreatic extracts.
  4. [4] Kimball and Murlin, 1923, Aqueous Extracts of Pancreas III — the original report associated with the naming of glucagon.
  5. [5] Endotext, history of glucagon — Rochester, the investigators and later developments.
  6. [6] Endotext, fed and fasting physiology — glucose uptake and production across fed and fasting states.
  7. [7] Endotext, glucagon physiology — alpha-cell signaling, glycogen breakdown and production of new glucose.
  8. [8] DailyMed, U.S. prescribing information for Glucagon for Injection — severe hypoglycemia indication, dependence on liver glycogen and mechanism, sections 1.1, 5.4 and 12.1.
  9. [9] Müller and colleagues, Glucagon-like peptide 1 (GLP-1) — the effects of GLP-1 on insulin and glucagon secretion.

Credits

Henry Mahon photographed Charles Best and Frederick Banting on the roof of the University of Toronto Medical Building in August 1921. The photograph comes from the Thomas Fisher Rare Book Library and was reframed for the film. Archival photograph · CC BY 2.0

The film uses generated period imagery and medical illustrations, synthetic Tom narration and a generated instrumental score. Independent scientific review is pending. This film is for education.

Download the episode materials